2. QUALITATIVE AND QUANTITATIVE COMPOSITION
The safety and efficacy of Neulastim in children aged below 18years have not yet been established. Currently available data are described in section 5.2 but no
Download 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Sickle Cell - APHON
aphon.org1 n WHAT IS SICKLE CELL DISEASE? Sickle cell disease is an inherited blood disorder that affects the ability of red blood cells to carry oxygen throughout the body. Normally, red blood cells are round and flexible.
Continuous and discontinuous variation - …
biologymad.comContinuous and discontinuous variation Variation, the small differences that exist between individuals, can be described as being either discontinuous or continuous. ...
Variations, Continuous, Continuous and discontinuous variation, Discontinuous
EXERCISE 11 – MENDELIAN GENETICS PROBLEMS
www.africangreyparrott.com-11. 5-2. In humans, sickle-cell anemia is caused by a recessive lethal allele Hbs; individuals who are HbaHbs have sickle-cell trait, but are healthy.
Exercise, Problem, Genetic, Cells, Traits, Mendelian, Sickle, Exercise 11 mendelian genetics problems, Sickle cell trait
www.downstatesurgery.org Perioperative …
www.downstatesurgery.orgPerioperative Management of Patients with Sickle Cell Disease November 29 th, 2012 David Vivas, MD www.downstatesurgery.org
Patients, With, Management, Cells, Perioperative, Sickle, Perioperative management of patients with sickle cell
Study of surgical aspects of sickle cell disease ...
www.ijbamr.comIndian Journal of Basic and Applied Medical Research; March 2015: Vol.-4, Issue- 2, P. 345-357 346 www.ijbamr.com P ISSN: 2250-284X , E ISSN : 2250-2858
Disease, Aspects, Surgical, Cells, Surgical aspects of sickle cell disease, Sickle
Sickle Cell Disease in Nigeria -----------A Review
www.iosrjournals.orgSickle Cell Disease in Nigeria -----A Review DOI: 10.9790/0853-1601048794 www.iosrjournals.org 88 | Page
Hemoglobinopathies: Sickle Cell Disease (HbSS, …
www.perinatalservicesbc.caPage 1 of 2 What is Sickle Cell Disease? Sickle cell disease is an inherited form of anemia. Under certain conditions, the red blood cells acquire a crescent, or ‘sickle’